期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 23, 期 1-2, 页码 25-35出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2012.01.003
关键词
Therapy; Angiogenesis; Metastasis
资金
- National Cancer Institute, National Institutes of Health [R01-CA129956, R01-CA148954, R01CA152309]
- National Natural Science Foundation of China [81101844]
Pancreatic cancer progression is attributed to genetic and epigenetic alterations and a chaotic tumor microenvironment. Those diverse upstream signal factors appear to converge on specific sets of central nuclear regulators, namely, transcription factors. Specificity Protein 1 (Sp1) and signal transducer and activator of transcription 3 (Stat3) are central transcription factors that regulate a number of pathways important to tumorigenesis, including tumor cell-cycle progression, apoptosis, angiogenesis, metastasis, and evasion of the immune system. Recently, researchers demonstrated many types of crosstalk of Sp1 and Stat3 in tumor signal transduction and that these factors function cooperatively to activate targeted genes and promote tumorigenesis in pancreatic cancer. Therefore, targeting both Sp1 and Stat3 is a potential preventive and therapeutic strategy for pancreatic cancer. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据